Department of Cardiology and Cardiovascular Surgery in Medicine School in Sao Jose do Rio Preto-FAMERP, Brazil.
Epidemiology Service of Hospital de Base São José do Rio Preto-Brazil.
Med Arch. 2024;78(2):146-148. doi: 10.5455/medarh.2024.78.146-148.
Patients with COVID-19 are at greater risk of pulmonary embolism.
The aim of the present study was to evaluate the monthly prevalence of pulmonary embolism diagnosed by angiotomography and mortality between March 2020 and May 2021 in more than 6000 patients hospitalized with COVID-19 at a single institution.
A clinical trial was conducted with evaluated medical records the patients hospitalized at the institution who developed pulmonary embolism determined by angiotomography. Monthly and overall mortality rates between March 2020 and May 2021 in this population were evaluated.
A total of 6040 patients were hospitalized in this period, 203 of whom (3.36%) had an angiotomographic diagnosis of pulmonary embolism and 119 of these patients (58.62%) died. The largest number of patients with pulmonary embolism occurred in the periods from July to September 2020 and March to May 2021. No significant difference was found between mortality and the two peaks of the pandemic (p = 0.9, Fisher's exact test).
Pulmonary embolism is associated a higher mortality rate among patients with COVID-19. Therefore, one of the strategies is an emphasis on the prevention of thrombotic and embolic events.
COVID-19 患者发生肺栓塞的风险更高。
本研究旨在评估 2020 年 3 月至 2021 年 5 月期间在一家机构住院的 6000 多名 COVID-19 患者中通过血管造影诊断的肺栓塞以及死亡率的每月患病率。
对在该机构住院并通过血管造影确定为肺栓塞的患者进行了临床试验，评估了他们的病历。评估了该人群 2020 年 3 月至 2021 年 5 月期间的每月和总体死亡率。
在此期间共有 6040 名患者住院，其中 203 名（3.36%）患者血管造影诊断为肺栓塞，其中 119 名（58.62%）患者死亡。肺栓塞患者数量最多的时期为 2020 年 7 月至 9 月和 2021 年 3 月至 5 月。在死亡率和大流行的两个高峰期之间未发现差异（p=0.9，Fisher 确切检验）。
COVID-19 患者肺栓塞与更高的死亡率相关。因此，策略之一是强调预防血栓形成和栓塞事件。
